HLA-G and chronic kidney disease: Studies have also shown that factors such as dialysis vintage, low basal metabolic rate [34, 37], low bone mass [57, 66], high Charlson comorbidity index (CCI) [44, 49], lowdaily steps [62, 69], low functional capacity [35, 39], and high β2‐microglobulin (β2‐MG) [20, 55] are risk factors for the development of sarcopenia in patients with CKD.